A crossover intervention trial to evaluate the impact of rapid on-admission screening in preventing Methicillin Resistant Staphylococcus Aureus (MRSA) infection in surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN06603006

Enrollment

20000

Registered

2007-09-05

Start date

2004-07-01

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRSA (Methicillin-resistant Staphylococcus aureus) Infections and Infestations Staphylococcus infection

Interventions

We carried out a prospective, interventional cohort study using a cross-over design to compare the effect of two different MRSA control strategies (rapid MRSA screening plus standard control versus st

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to the surgical department for greater than 24 hours

Exclusion criteria

Exclusion criteria: Ambulatory surgery

Design outcomes

Primary

Measure	Time frame
Number of patients with nosocomial MRSA infection acquired in surgery, expressed as incidence per 1000 patient-days.	—

Secondary

Measure	Time frame
1. Nosocomial MRSA acquisition rate (expressed as the rate of new MRSA cases detected by any type of clinical isolate in previously MRSA-free patients per 1000 patient-days) 2. The rate of surgical site infections (per 100 procedures) and other site-specific infections caused by MRSA	—

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026